Trial Profile
Treatment with entecavir or tenofovir disoproxil fumarate in mono-infected patients with chronic hepatitis B in a real-world setting: the MENTE study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Acronyms MENTE
- 31 Aug 2015 New trial record